EDITORIAL
Published on 30 May 2022
Editorial: The Role of the EMT Program in Regulating the Immune Response in Carcinoma
doi 10.3389/fimmu.2022.940164
- 1,851 views
- 4 citations
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- The Role of the EMT Program in Regulating the Immune Response in Carcinoma
The Role of the EMT Program in Regulating the Immune Response in Carcinoma
15k
Total Downloads
45k
Total Views and Downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 27 Apr 2022
Dissecting the Role of AXL in Cancer Immune Escape and Resistance to Immune Checkpoint Inhibition
doi 10.3389/fimmu.2022.869676
- 12,487 views
- 34 citations
ORIGINAL RESEARCH
Published on 07 Apr 2022
Stemness Subtypes and Scoring System Predict Prognosis and Efficacy of Immunotherapy in Soft Tissue Sarcoma
doi 10.3389/fimmu.2022.796606
- 2,824 views
- 3 citations
REVIEW
Published on 29 Mar 2022
Cancer Cell Phenotype Plasticity as a Driver of Immune Escape in Melanoma
doi 10.3389/fimmu.2022.873116
- 5,506 views
- 16 citations
ORIGINAL RESEARCH
Published on 25 Feb 2022
PRRX1 Is a Novel Prognostic Biomarker and Facilitates Tumor Progression Through Epithelial–Mesenchymal Transition in Uveal Melanoma
doi 10.3389/fimmu.2022.754645
- 4,303 views
- 15 citations
ORIGINAL RESEARCH
Published on 15 Dec 2021
Immunosuppressive Traits of the Hybrid Epithelial/Mesenchymal Phenotype
doi 10.3389/fimmu.2021.797261
- 4,680 views
- 63 citations
REVIEW
Published on 02 Nov 2021
Selective Inhibitor of the c-Met Receptor Tyrosine Kinase in Advanced Hepatocellular Carcinoma: No Beneficial Effect With the Use of Tivantinib?
doi 10.3389/fimmu.2021.731527
- 5,189 views
- 14 citations
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 45kTopic views
- 29kArticle views
- 15kArticle downloads